期刊文献+

星点设计效应面法优化胰岛素油溶液的处方 被引量:1

Application of central composite design-response surface methodology to the preparation of insulin oil solution
下载PDF
导出
摘要 目的采用中心复合设计法优化胰岛素-胆盐与磷脂冻干复合物处方,以获得稳定的胰岛素油溶液。方法分别考察了叔丁醇用量和胆盐与磷脂质量比对冻干复合物的载药量和溶解时所需油相质量等指标的影响。用线性方程和二次多项式描述各指标及总评"归一值"与两个因素之间的数学关系,根据总评"归一值"的最佳数学模型描绘效应面,选择最佳处方,并进行预测分析。结果两个因素和两个评价指标及总评"归一值"之间存在定量关系。优选的最佳处方为叔丁醇0.475 g,胆盐与磷脂质量比2.810。优化处方各指标的预测值和目标值接近。结论所建立的模型预测性良好,可用于优化胰岛素-胆盐与磷脂冻干复合物处方,并获得稳定的胰岛素油溶液。 Objective To obtain a stable oil solution loaded insulin, the formulations of bile salt/SPC freeze- dried complex were prepar.ed and optimized using central composite design-response surface methodology. Methods The effect of formulation variables( amount of ten-butyl alcohol, and ratio of bile salt/SPC) on a number of response variables was systemically investigated. The response variables were^amount of solubiliz- ing insulin in freeze-dried complex and amount of soybean oil used to dissolve freeze-dried complex. A de- sirability function that combines these two response variables was constructed. A second-order polynomial eqution was. fitted to the data, and the resulting eqution was used to perdict the responses in the optimal re- gion. Results All the investigated response variables were found to be highly dependent on the formulation variables. It was found that optimum overall desirability of the insulin freeze-dried complex could be ob- tained at 0. 475 g of ten-butyl alcohol, and at 2. 810 of ratio of bile salt/SPC. The experimental values of the response variables highly agreed with the predict values. Conclusions Central composite design-response sur- face methodology is successfully used to optimize the preparation of insulin-loaded bile salt/SPC freeze- dried complex, in order to obtain the stable insulin oil solution. Overall desirability can be used to represent the most desirable variables in experimental design.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2012年第9期673-677,707,共6页 Journal of Shenyang Pharmaceutical University
关键词 胰岛素 胆盐与磷脂冻干复合物 混合反胶束 星点设计 效应面 insulin bile salt/SPC freeze-dried complex mixed reverse micelle central composite design response surface
  • 相关文献

参考文献10

  • 1BERNKOP-SCHNUREH A. The use of inhibitory a- gents to overcome the enzymatic barrier to perorally administrated therapeutic peptides and proteins [ J ]. J Control Release, 1998,52 (1/2) : 1 - 16.
  • 2FIX J A. Strategies for delivery of peptides utilizing absorption-enhancing agents [ J ] J Pharm Sei, 1996, 85 (12) : 1282 - 1285.
  • 3NEW P R C. Liposiomes : a practical approach [ M ]. New York: Oxford University Press, 1990:75 - 89.
  • 4吴伟,崔光华.星点设计-效应面优化法及其在药学中的应用[J].国外医学(药学分册),2000,27(5):292-298. 被引量:426
  • 5刘艳杰,项荣武.星点设计效应面法在药学试验设计中的应用[J].中国现代应用药学,2007,24(6):455-457. 被引量:238
  • 6ISKANDARANI B, CLAIR J H, PATEL P, et al. Simultaneous optimization of capsule and tablet for- mulation using response surface methodology [ J ]. Drug Dev Ind Pharm,1993,19(16) :2089 -2101.
  • 7ABU-IZZA K A, GARCIA-CONTRERAS L,LU D R. Preparation and evaluation of sustained release AZT-loaded microspheres:optimization of the release characteristics using response surface methodology [J]. J Pharm Sci,1996,85(2) :144 - 149.
  • 8ABU-IZZA K A, GARCIA-CONTRERAS L, LU D R. Preparation and evaluation of zidovudine-loaded sustained-release microspheres: Optimization of multi- ple response variable [ J ]. J Pharm Sci, 1996,85 (6) : 572 - 576.
  • 9吴伟,崔光华,陆彬.实验设计中多指标的优化:星点设计和总评“归一值”的应用[J].中国药学杂志,2000,35(8):530-533. 被引量:310
  • 10HASSAN E E, PARISH R C, GALLO J M. Opti- mized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole [ J ]. Pharm Res, 1992,9 (3) :390 - 397.

二级参考文献19

共引文献825

同被引文献24

  • 1刘春晖,林巧平,山莽挺,祁智,许向阳.茴三硫固体分散体的体内外评价[J].中国现代应用药学,2013,30(1):47-52. 被引量:3
  • 2刘绛光,王俊敏,何应.微乳在口服多肽类药物中的应用[J].中国生化药物杂志,2006,27(1):56-58. 被引量:8
  • 3刘春晖,陈云,于霞,许向阳.茴三硫微粉化片剂的研制[J].海峡药学,2007,19(4):21-23. 被引量:4
  • 4SHARMA S ,PU G,VERNON E S. Quantitative mor- phometry of respiratory tract epithelial cells as a tool for testing chemopreventive agent efficacy [ J ]. Anti- cancer Research,2010,30 ( 3 ) :737 - 742.
  • 5KHOSROW K, KENNETH R O. Biology and thera- peutic potential of hydrogen sulfide and hydrogen sul- fide - releasing chimeras [ J ]. Biochemical Pharmacol- ogy, 2013,85 ( 5 ) : 689 - 703.
  • 6BRUCE K S. Potential biological chemistry of hydro- gen sulfide(H < sub > 2 </sub > S)with the nitro- gen oxides [ J ]. Free Radical Biology and Medicine, 2013,55:1 -7.
  • 7MITALI C, RAVINDER K, KENNETH R O, et al. NOSH-aspirin( NBS- 1120 ), a novel nitric oxide-and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth < i > in vitro </i > and in a xenograft mouse model[ J]. Biochemical and Bio- physical Research Communications, 2012,419 ( 3 ) : 523 - 528.
  • 8HAN Si-fei, YAO Ting-fing, ZHANG Xin-xin, et al. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione:effects of lipid composition and formulation [ J ]. International Journal of Pharmaceutics,2009,379(1 ) : 18 - 24.
  • 9邓意辉,赵静,董晓辉,等.一种复合型乳化剂及用其制备的乳剂及其制备方法:中国.200710012275.7[P].2007-07-26.
  • 10刘艳杰,项荣武.星点设计效应面法在药学试验设计中的应用[J].中国现代应用药学,2007,24(6):455-457. 被引量:238

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部